Semaglutide is a medication proven to be one of the best weight loss medications available at this time with minimal side effects. Semaglutide is administered as a subcutaneous injection once a week and has been shown to improve blood sugar control, reduce body weight, and lower the risk of cardiovascular events in certain patients. In addition, semaglutide has also been approved by the FDA for use in treating obesity.
Semaglutide has several benefits for people with Type 2 diabetes and obesity:
Improved blood sugar control: Semaglutide works by mimicking the effects of GLP-1, a hormone that helps regulate blood sugar levels. By increasing insulin secretion and decreasing glucagon secretion, semaglutide can help lower blood sugar levels and improve glycemic control.
Weight loss: Semaglutide has been approved as a weight loss medication under the brand name Wegovy. It works by reducing appetite and slowing down the rate at which food is absorbed from the stomach. Studies have shown that semaglutide can lead to significant weight loss in people with obesity.
Cardiovascular benefits: Semaglutide has been shown to have cardiovascular benefits, including reducing the risk of heart attacks, strokes, and cardiovascular death in people with Type 2 diabetes and high cardiovascular risk.
Reduced risk of kidney disease: Semaglutide has also been shown to reduce the risk of kidney disease progression in people with Type 2 diabetes and chronic kidney disease.
Convenience: Semaglutide is administered by injection once a week, which may be more convenient for some people compared to daily injections or multiple daily doses of oral medication.
It is important to note that like any medication, semaglutide may have side effects and risks, and should only be used under the guidance of a physician.
Currently, semaglutide is not covered by insurance in Canada. This may change in the future as
semaglutide continues to be studied for its potential health benefits.
Here are some factors that may make someone a candidate for semaglutide:
Type 2 diabetes: Semaglutide is approved for the treatment of Type 2 diabetes in adults. It may be suitable for people with Type 2 diabetes who have not achieved adequate blood sugar control with other medications and lifestyle changes.
Obesity: Semaglutide is also approved for the treatment of obesity in adults. It may be suitable for people with a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition, such as high blood pressure or Type 2 diabetes.
Comorbidities: Semaglutide may be beneficial for people with other health conditions that are commonly associated with Type 2 diabetes or obesity, such as high blood pressure, high cholesterol, and cardiovascular disease.
Medication adherence: Semaglutide is administered by injection once a week, which may be more convenient for some people who have difficulty adhering to daily oral medication regimens.
Health goals: Semaglutide may be suitable for people who have specific health goals, such as improving blood sugar control, losing weight, or reducing the risk of cardiovascular disease.
Semaglutide is administered by injection once a week. The starting dose is usually 0.25 mg per week, which is gradually increased to 1.0 mg per week over several weeks. The dose may be adjusted based on individual response and tolerability.
Like any medication, Semaglutide may cause side effects. Some of the common side effects that have been reported in clinical trials include:
These side effects usually occur early in treatment and may improve over time as the body adjusts to the medication. In some cases, the healthcare provider may recommend starting at a lower dose and gradually increasing the dose to reduce the likelihood of side effects.
Less common but potentially serious side effects may include:
Dr. Shawn Seit is one of the top cosmetic physicians and educators in Canada over the last 18 years. He is the creator and Medical Director of Rejuuv Medi Spa Clinics in Canada . He is a graduate of University of Toronto Medical school and has trained with the top two plastic surgeons in Canada, Dr Steve Mulholland and Dr Arthur Swift and travelled to London, Paris , Monaco, Prague , Korea and Switzerland to further his training with some of the top cosmetic physicians and lecturers in the world. He believes in creating beautiful and natural looking results for all his clients which include models , actors and singers in the entertainment industry in Hollywood, Canada, Hong Kong and China. His passion and love for his work comes from the reward of seeing all the positive effects of confidence, happiness and inner growth of his patients.